124 related articles for article (PubMed ID: 30705106)
21. Expression of SOX9 and CDX2 in nongoblet columnar-lined esophagus predicts the detection of Barrett's esophagus during follow-up.
Zhang X; Westerhoff M; Hart J
Mod Pathol; 2015 May; 28(5):654-61. PubMed ID: 25412842
[TBL] [Abstract][Full Text] [Related]
22. Bile acids but not acidic acids induce Barrett's esophagus.
Sun D; Wang X; Gai Z; Song X; Jia X; Tian H
Int J Clin Exp Pathol; 2015; 8(2):1384-92. PubMed ID: 25973022
[TBL] [Abstract][Full Text] [Related]
23. Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma.
Derks S; Nason KS; Liao X; Stachler MD; Liu KX; Liu JB; Sicinska E; Goldberg MS; Freeman GJ; Rodig SJ; Davison JM; Bass AJ
Cancer Immunol Res; 2015 Oct; 3(10):1123-1129. PubMed ID: 26081225
[TBL] [Abstract][Full Text] [Related]
24. In-depth characterization of the Wnt-signaling/β-catenin pathway in an in vitro model of Barrett's sequence.
Götzel K; Chemnitzer O; Maurer L; Dietrich A; Eichfeld U; Lyros O; Moulla Y; Niebisch S; Mehdorn M; Jansen-Winkeln B; Vieth M; Hoffmeister A; Gockel I; Thieme R
BMC Gastroenterol; 2019 Mar; 19(1):38. PubMed ID: 30841855
[TBL] [Abstract][Full Text] [Related]
25. Pathogenesis of Barrett's esophagus: bile acids inhibit the Notch signaling pathway with induction of CDX2 gene expression in human esophageal cells.
Morrow DJ; Avissar NE; Toia L; Redmond EM; Watson TJ; Jones C; Raymond DP; Litle V; Peters JH
Surgery; 2009 Oct; 146(4):714-21; discussion 721-2. PubMed ID: 19789031
[TBL] [Abstract][Full Text] [Related]
26. Roles of caudal-related homeobox gene Cdx1 in oesophageal epithelial cells in Barrett's epithelium development.
Kazumori H; Ishihara S; Kinoshita Y
Gut; 2009 May; 58(5):620-8. PubMed ID: 19136512
[TBL] [Abstract][Full Text] [Related]
27. COX-2, CDX2, and CDC2 immunohistochemical assessment for dysplasia-carcinoma progression in Barrett's esophagus.
Villanacci V; Rossi E; Zambelli C; Galletti A; Cestari R; Missale G; Casa DD; Bassotti G
Dig Liver Dis; 2007 Apr; 39(4):305-11. PubMed ID: 17307036
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.
Sreedharan L; Mayne GC; Watson DI; Bright T; Lord RV; Ansar A; Wang T; Kist J; Astill DS; Hussey DJ
World J Gastroenterol; 2017 Aug; 23(30):5508-5518. PubMed ID: 28852310
[TBL] [Abstract][Full Text] [Related]
29. Molecular mechanisms of Barrett's esophagus and adenocarcinoma.
Dvorak K; Goldman A; Kong J; Lynch JP; Hutchinson L; Houghton JM; Chen H; Chen X; Krishnadath KK; Westra WM
Ann N Y Acad Sci; 2011 Sep; 1232():381-91. PubMed ID: 21950830
[TBL] [Abstract][Full Text] [Related]
30. Guggulsterone, a plant-derived inhibitor of NF-TB, suppresses CDX2 and COX-2 expression and reduces the viability of esophageal adenocarcinoma cells.
Yamada T; Osawa S; Ikuma M; Kajimura M; Sugimoto M; Furuta T; Iwaizumi M; Sugimoto K
Digestion; 2014; 90(3):208-17. PubMed ID: 25427631
[TBL] [Abstract][Full Text] [Related]
31. Frequent methylation of eyes absent 4 gene in Barrett's esophagus and esophageal adenocarcinoma.
Zou H; Osborn NK; Harrington JJ; Klatt KK; Molina JR; Burgart LJ; Ahlquist DA
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):830-4. PubMed ID: 15824152
[TBL] [Abstract][Full Text] [Related]
32. Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans.
Tan MC; El-Serag HB; Yu X; Thrift AP
Aliment Pharmacol Ther; 2018 Aug; 48(4):469-477. PubMed ID: 29956826
[TBL] [Abstract][Full Text] [Related]
33. Aspirin prevents NF-κB activation and CDX2 expression stimulated by acid and bile salts in oesophageal squamous cells of patients with Barrett's oesophagus.
Huo X; Zhang X; Yu C; Cheng E; Zhang Q; Dunbar KB; Pham TH; Lynch JP; Wang DH; Bresalier RS; Spechler SJ; Souza RF
Gut; 2018 Apr; 67(4):606-615. PubMed ID: 28442495
[TBL] [Abstract][Full Text] [Related]
34. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN
Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844
[TBL] [Abstract][Full Text] [Related]
35. Immature myeloid progenitors promote disease progression in a mouse model of Barrett's-like metaplasia.
Kong J; Sai H; Crissey MA; Jhala N; Falk GW; Ginsberg GG; Abrams JA; Nakagawa H; Wang K; Rustgi AK; Wang TC; Lynch JP
Oncotarget; 2015 Oct; 6(32):32980-3005. PubMed ID: 26460825
[TBL] [Abstract][Full Text] [Related]
36. Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett's epithelium.
Kazumori H; Ishihara S; Rumi MA; Kadowaki Y; Kinoshita Y
Gut; 2006 Jan; 55(1):16-25. PubMed ID: 16118348
[TBL] [Abstract][Full Text] [Related]
37. Roles of Kruppel-like factor 4 in oesophageal epithelial cells in Barrett's epithelium development.
Kazumori H; Ishihara S; Takahashi Y; Amano Y; Kinoshita Y
Gut; 2011 May; 60(5):608-17. PubMed ID: 21193454
[TBL] [Abstract][Full Text] [Related]
38. Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus.
Clément G; Braunschweig R; Pasquier N; Bosman FT; Benhattar J
Oncogene; 2006 May; 25(21):3084-92. PubMed ID: 16407829
[TBL] [Abstract][Full Text] [Related]
39. [Expression of transcription factor in Barrett's esophagus].
Mutoh H
Nihon Rinsho; 2005 Aug; 63(8):1367-71. PubMed ID: 16101223
[TBL] [Abstract][Full Text] [Related]
40. Expression of the bile acid receptor FXR in Barrett's esophagus and enhancement of apoptosis by guggulsterone in vitro.
De Gottardi A; Dumonceau JM; Bruttin F; Vonlaufen A; Morard I; Spahr L; Rubbia-Brandt L; Frossard JL; Dinjens WN; Rabinovitch PS; Hadengue A
Mol Cancer; 2006 Oct; 5():48. PubMed ID: 17054793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
